Trial Condition(s):

Diagnostic Imaging, Central Nervous System

Open clinical study with Gd-DTPA (gadopentetate dimeglumine) in cerebral and spinal diseases

Bayer Identifier:

Trial_A23BSA

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

443

Trial Dates

March1986

April1987

Phase

Could I receive a placebo?

Products

Magnevist (Gadopentetate Dimeglumine, BAY86-4882)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

Diagnostic Imaging, Central Nervous System

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

5 Years

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information